• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde (CAS No. 1098984-10-1) and Its Recent Applications in Chemical Biology

2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde, identified by the chemical abstracts service number CAS No. 1098984-10-1, is a versatile organic compound that has garnered significant attention in the field of chemical biology due to its unique structural and functional properties. This aromatic aldehyde features both hydroxyl and aldehyde functional groups, making it a valuable intermediate in the synthesis of various bioactive molecules. Its molecular structure, characterized by a phenolic ring system, positions it as a promising candidate for further exploration in drug discovery and therapeutic development.

The compound's dual functionality—the presence of both hydroxyl and aldehyde groups—enables diverse chemical transformations, which are highly beneficial for medicinal chemistry applications. The hydroxyl groups contribute to hydrogen bonding capabilities, enhancing interactions with biological targets, while the aldehyde moiety serves as a reactive site for condensation reactions, such as Schiff base formation. These attributes make 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde a valuable building block in the design of novel pharmacophores.

In recent years, there has been growing interest in exploring the pharmacological potential of 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde and its derivatives. Studies have demonstrated its efficacy in modulating various biological pathways, including antioxidant, anti-inflammatory, and anticancer activities. For instance, research published in peer-reviewed journals has highlighted its role in inhibiting key enzymes involved in cancer cell proliferation. The compound's ability to interact with biological targets at the molecular level underscores its significance as a lead compound in drug development pipelines.

One of the most compelling aspects of 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde is its potential as a scaffold for structure-activity relationship (SAR) studies. By modifying its functional groups or substituents, researchers can fine-tune its biological activity to achieve desired therapeutic effects. This flexibility has led to the synthesis of several derivatives that exhibit enhanced potency and selectivity against specific disease targets. Such modifications are crucial for optimizing drug candidates and improving their pharmacokinetic profiles.

The compound's structural similarity to naturally occurring phenolic compounds also makes it an attractive candidate for natural product-inspired drug design. Many bioactive molecules isolated from plants and microorganisms share structural motifs with 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde, suggesting that it could serve as a template for discovering novel therapeutics. Additionally, its compatibility with green chemistry principles—such as solubility in aqueous media and biodegradability—further enhances its appeal as a pharmaceutical intermediate.

Advances in computational chemistry have also played a pivotal role in understanding the mechanistic aspects of 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde's interactions with biological targets. Molecular docking simulations and quantum mechanical calculations have provided insights into how this compound binds to enzymes and receptors, offering valuable guidance for rational drug design. These computational approaches complement experimental studies, enabling researchers to predict the efficacy of potential drug candidates with greater accuracy.

The synthesis of 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde can be achieved through multiple pathways, each offering distinct advantages in terms of yield, purity, and scalability. Traditional methods involving condensation reactions between appropriate precursors remain widely used, while newer techniques such as catalytic asymmetric synthesis are being explored to improve enantioselectivity. The development of efficient synthetic routes is essential for large-scale production and industrial applications.

In conclusion, 2-hydroxy-5-(3-hydroxyphenyl)benzaldehyde (CAS No. 1098984-10-1) represents a promising compound with significant potential in chemical biology and drug discovery. Its unique structural features, coupled with its diverse biological activities, make it an ideal candidate for further exploration. As research continues to uncover new applications for this molecule, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 757995-89-4([1,1-Biphenyl]-3-carboxaldehyde, 4,5-dihydroxy- (9CI))
• 893738-02-8(2-hydroxy-5-(3-methylphenyl)benzaldehyde)
• 84783-76-6([1,1'-Biphenyl]-4-carboxaldehyde,2',5'-dihydroxy-)
• 1761-63-3(2-hydroxy-5-phenylbenzaldehyde)
• 1261892-15-2(2-hydroxy-4-naphthalen-2-ylbenzaldehyde)
• 1261895-07-1(2-hydroxy-4-(2-hydroxyphenyl)benzaldehyde)
• 35664-67-6(2-hydroxy-4-phenylbenzaldehyde)
• 198900-51-5(2-hydroxy-5-(4-hydroxyphenyl)benzaldehyde)
• 1014625-94-5(2-hydroxy-4-(4-hydroxyphenyl)benzaldehyde)
• 1258637-02-3(2-hydroxy-3-(3-hydroxyphenyl)benzaldehyde)